Andrew Callos, EVP, Chief Commercial Officer at CYTOKINETICS INC (CYTK), sold 15,857 shares at $65.00 ($1.0M) on 2026-05-01, disclosed to the SEC on 2026-05-04.
Open-market sale of $1.0M CYTK by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CYTK | SELL | 2026-07-02 | $1.3M | — | Filing → |
| CYTK | SELL | 2026-06-01 | $1.1M | — | Filing → |
| CYTK | SELL | 2026-05-05 | $875K | — | Filing → |